Progression of Pentosan Polysulfate Sodium (PPS) Maculopathy in a Prospective Cohort.

American journal of ophthalmology(2023)

引用 0|浏览0
暂无评分
摘要
Eyes with baseline PPS maculopathy all exhibited remarkable progression with qualitative and quantitative multimodal imaging analysis despite drug discontinuation. Disease progression may be attributed to underlying inner choroidal ischemia or RPE impairment.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要